AIA Group »

Karuna Therapeutics Ord shares owned by AIA Group

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by AIA Group from 13F filings

Historical chart of AIA Group investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by AIA Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by AIA Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 3.6k 316.51

More positions owned by AIA Group

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Texas Instruments Incorporated (TXN)
Deere & Company (DE)
Visa Com Cl A (V)
Cisco Systems (CSCO)
Northern Trust Corporation (NTRS)
Edwards Lifesciences (EW)
Home Depot (HD)
Procter & Gamble Company (PG)
Merck & Co (MRK)
J P Morgan Exchange Traded F Betabuldrs Japan (BBJP)
Danaher Corporation (DHR)

View all positions for AIA Group

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord